Raymed Labs Ltd.

View in App
2.46 ▼0%

20 November 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.raymedlab.com
Market Cap 1.05 Cr.
Enterprise Value(EV) 1.05 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.30 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.68 Trailing Twelve Months Ending 2023-09
Book Value / Share -5.47 Trailing Twelve Months Ending 2023-09
Price to Book Value -0.45 Calculated using Price: 2.46
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.43 Cr. 4,273,500 Shares
FaceValue 10
About Raymed Labs Ltd.
Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed's quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.

Raymed Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Raymed Labs Ltd. Performance

View details >>
1 Day
1 Week
1 Month
3 Month
+4.68%
6 Month
+14.95%
1 Year
+38.20%
2 Year
+138.83%
5 Year
+3.80%
10 Year
-79.40%

Raymed Labs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%)
Return on Capital Employed (%) -7.11 -15.55 -26.39 -41.34 -58.42 -105.49 -94.35
Return on Assets (%) -6.08 -12.90 -17.98 -20.71 -20.01 -21.34 -27.07 -32.96 -85.07

Raymed Labs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -2 -2 -2 -2 -2 -2 -2 -2 -2 -2
Non Curr. Liab. 2 2 2
Curr. Liab. 2 2 2 2 2 2 2 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0 0
Non Curr. Assets 0 0 0 0 0 0 0 0 0 0
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0 0

Raymed Labs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales
Other Income 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest
Depreciation 0 0 0 0 0 0 0 0
Taxation
Exceptional Items 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Raymed Labs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -2 0
Cash Fr. Inv. 0 2 0
Cash Fr. Finan. 0 0 0
Net Change 0
Cash & Cash Eqvt

Raymed Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 28.36 28.36 28.36 28.36 28.36 28.36 28.36 28.36 28.36
Public 71.64 71.64 71.64 71.64 71.64 71.64 71.64 71.64 71.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Raymed Labs Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Un-Audited Standalone Financial Results For The Quarter And Half Year Ended September 30 2023
Approval of Un-audited Standalone Financial Results for the Quarter and Half Year ended September 30 2023
Mon, 06 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Un-audited Standalone Financial Result for the quarter and half year ended 30.09.2023
Sat, 04 Nov 2023
Outcome Of Board Meeting Dated 04/11/2023
Outcome of Board Meeting dated 04/11/2023

Raymed Labs Ltd. Technical Scans

View details >>

No Scans Found

Raymed Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 294,434.39 1,233.85 +0.6%
Divi's Laboratories Ltd. 100,534.28 3,809.15 +0.5%
Cipla Ltd. 97,810.50 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. 96,539.80 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. 79,515.07 5,587.00 +1.0%
Mankind Pharma Ltd. 75,494.90 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. 71,999.19 2,153.20 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.44 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-09 75.49 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-09 28.32 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.96 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.00 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 58.89 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.97 2,153.20 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.92 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-09 7.93 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-09 3.94 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.79 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.23 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8.96 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.73 2,153.20 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,153.20 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,153.20 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,153.20 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,153.20 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,233.85 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,809.15 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,206.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,796.95 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,587.00 +1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,925.00 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,153.20 +1.2%

Raymed Labs Ltd. FAQ's

What is Raymed Labs share price?
Can I buy Raymed Labs shares now?
What is the Market Cap of Raymed Labs?
What is the 52 Week High and Low of Raymed Labs?